E
PharmaCielo Ltd. PCLO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 5.83% 29.47% 31.79% -118.84% 48.09%
Total Depreciation and Amortization -107.69% -86.22% -71.77% 107.28% 24.65%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 62.96% 90.25% -43.29% 26.55% -27.96%
Change in Net Operating Assets -103.48% -147.39% 92.85% 169.17% -85.33%
Cash from Operations 40.51% 62.53% 63.30% 7.50% 50.74%
Capital Expenditure -- -- -- 91.52% 99.84%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -100.00% -100.00% -82.30% -14.37% 396.55%
Cash from Investing -100.00% -100.00% -81.32% 9.36% 118.14%
Total Debt Issued -100.00% -55.33% -75.39% 15.24% -47.53%
Total Debt Repaid 8.46% -18.95% 20.16% -41.35% 25.65%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -31.66% -60.57% -59.09% 7.05% -50.37%
Foreign Exchange rate Adjustments 16.67% 10.81% -72.16% 141.55% --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 82.67% 62.05% -59.97% 114.98% 86.63%
Weiss Ratings